Histogen HSTO Stock
Histogen Price Chart
Histogen HSTO Financial and Trading Overview
| Histogen stock price | 0.5 USD |
| Previous Close | 0.83 USD |
| Open | 0.81 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 0.81 - 0.89 USD |
| 52 Week Range | 0.68 - 4.76 USD |
| Volume | 8.15K USD |
| Avg. Volume | 979.11K USD |
| Market Cap | 3.63M USD |
| Beta (5Y Monthly) | 1.044333 |
| PE Ratio (TTM) | 0.7522124 |
| EPS (TTM) | -2.81 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2 USD |
HSTO Valuation Measures
| Enterprise Value | -2569440 USD |
| Trailing P/E | 0.7522124 |
| Forward P/E | -0.20631069 |
| PEG Ratio (5 yr expected) | -0.01 |
| Price/Sales (ttm) | 191.10506 |
| Price/Book (mrq) | 0.31978932 |
| Enterprise Value/Revenue | -135.234 |
| Enterprise Value/EBITDA | 0.193 |
Trading Information
Histogen Stock Price History
| Beta (5Y Monthly) | 1.044333 |
| 52-Week Change | -63.20% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.76 USD |
| 52 Week Low | 0.68 USD |
| 50-Day Moving Average | 0.91 USD |
| 200-Day Moving Average | 1.11 USD |
HSTO Share Statistics
| Avg. Volume (3 month) | 979.11K USD |
| Avg. Daily Volume (10-Days) | 42.27K USD |
| Shares Outstanding | 4.27M |
| Float | 3.92M |
| Short Ratio | 0.65 |
| % Held by Insiders | 2.86% |
| % Held by Institutions | 7.79% |
| Shares Short | 42.6K |
| Short % of Float | 1.02% |
| Short % of Shares Outstanding | 1.00% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -70705.26% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.31% |
| Return on Equity (ttm) | -78.38% |
Income Statement
| Revenue (ttm) | 19K USD |
| Revenue Per Share (ttm) | 0.005 USD |
| Quarterly Revenue Growth (yoy) | -99.90% |
| Gross Profit (ttm) | -1252000 USD |
| EBITDA | -13287000 USD |
| Net Income Avi to Common (ttm) | -13906000 USD |
| Diluted EPS (ttm) | 1.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.66M USD |
| Total Cash Per Share (mrq) | 2.26 USD |
| Total Debt (mrq) | 4.58M USD |
| Total Debt/Equity (mrq) | 44.32 USD |
| Current Ratio (mrq) | 7.916 |
| Book Value Per Share (mrq) | 2.658 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -11888000 USD |
| Levered Free Cash Flow (ttm) | -2307250 USD |
Profile of Histogen
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 10655 Sorrento Valley Road |
| ZIP | 92121 |
| Phone | 858 526 3100 |
| Website | https://www.histogen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California.
Q&A For Histogen Stock
What is a current HSTO stock price?
Histogen HSTO stock price today per share is 0.5 USD.
How to purchase Histogen stock?
You can buy HSTO shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Histogen?
The stock symbol or ticker of Histogen is HSTO.
Which industry does the Histogen company belong to?
The Histogen industry is Biotechnology.
How many shares does Histogen have in circulation?
The max supply of Histogen shares is 4.27M.
What is Histogen Price to Earnings Ratio (PE Ratio)?
Histogen PE Ratio is now.
What was Histogen earnings per share over the trailing 12 months (TTM)?
Histogen EPS is -2.81 USD over the trailing 12 months.
Which sector does the Histogen company belong to?
The Histogen sector is Healthcare.
Histogen HSTO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}